Physician profile
Harold Bach
NPI 1215940838
$3,100.22
in general payments reported to CMS, 2019-2025
20 companies · $16.35 in 2025
The $16.35 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $140 · 2021: $1,490 · 2022: $128 · 2023: $49.52 · 2024: $718 · 2025: $16.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $245.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,417.00 | 2021 | |
| Medtronic USA, INC. | $447.26 | 2019 | |
| Stryker Corporation | $419.01 | 2024-2025 | Chesapeake Stabilization System, Monterey Al, Cascadia Interbody System |
| Spineology INC. | $245.70 | 2024 | Optimesh Expandable Interbody Fusion System |
| Si-Bone, INC. | $174.96 | 2019-2024 | |
| Corelink, LLC | $100.00 | 2022 | |
| Exact Sciences Corporation | $51.83 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $47.95 | 2021 | |
| Eisai INC. | $26.99 | 2020 | |
| Abbott Laboratories | $25.33 | 2019 | |
| Biodelivery Sciences International, INC. | $21.40 | 2020 | |
| Electronic Waveform Lab, INC. | $19.26 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $18.04 | 2019 | |
| Neurelis, INC. | $17.92 | 2021 | |
| Novo Nordisk INC | $14.65 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.05 | 2023 | |
| Merck Sharp & Dohme LLC | $13.83 | 2019 | |
| Amarin Pharma, INC. | $12.28 | 2020 | |
| Globus Medical, INC. | $6.66 | 2021 | |
| Orthofix Medical, INC. | $6.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$247,630.20 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Bach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.